Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced it is advancing regulatory and initial deployment activities for its telehealth platform in Venezuela. The company is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. Management anticipates the permitting process may be completed in the near term, though no assurance can be provided regarding timing or outcome.
The platform, accessible through its digital interface at https://latamedai.org, is currently undergoing early-stage deployment, testing, and refinement. The company is evaluating system performance, user workflows, and operational capabilities as part of its initial launch. The telehealth platform is designed to support remote patient engagement, care coordination, and integration of artificial intelligence-driven healthcare analytics tools within a technology-enabled healthcare environment. Current efforts focus on enhancing platform functionality, improving data integration, and optimizing the overall user experience.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: "Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals."
The company believes that this phase of deployment, testing, and regulatory alignment represents an important step in advancing its telehealth platform toward broader operational rollout across its target markets. Catalyst Crew Technologies is an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
This update underscores the company's progress in navigating the regulatory landscape in Venezuela, a key market for its expansion strategy. The successful completion of the permitting process and subsequent full launch could position Catalyst Crew to address the growing demand for modernized healthcare delivery systems across emerging markets. However, the company remains a development-stage enterprise and has not generated revenues from its newly announced business direction. Additional information is available on the company's website at https://catalystcrewai.com and in its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
